heat
shock
protein
hsp
success
appli
broad
rang
vaccin
biolog
adjuv
enhanc
immun
respons
recent
defin
particular
exhibit
strong
protein
bind
affin
capabl
enhanc
immunogen
protein
antigen
remark
hsp
famili
member
previou
studi
verifi
murin
significantli
enhanc
immun
respons
mous
model
restrict
human
papillomaviru
hpv
epitop
short
peptid
span
amino
acid
residu
protein
determin
whether
similarli
enhanc
immunogen
human
epitop
peptid
use
transgen
mous
model
investig
efficaci
chaperon
molecul
immunoadjuv
human
epitop
vaccin
result
show
effici
form
noncoval
bound
complex
epitop
complex
induc
epitopespecif
splenocyt
prolifer
specif
gamma
interferon
secret
importantli
cytotox
lymphocyt
prime
complex
exert
strong
cytolyt
effect
target
cell
puls
peptid
cell
transfect
gene
addit
complex
elicit
stronger
ex
vivo
vivo
antitumor
respons
either
emulsifi
complet
freund
adjuv
peptid
collect
data
suggest
promis
immunomodul
candid
peptidebas
human
cancer
vaccin
epitop
c
ervic
cancer
cacx
second
lead
caus
cancer
death
among
women
worldwid
cacx
strongli
associ
human
papillomaviru
hpv
infect
particularli
hpv
type
sever
clinic
studi
demonstr
constitut
express
oncoprotein
major
cervic
tumor
cell
sinc
cervic
tumor
often
recur
surgeri
andor
radiotherapi
critic
develop
prophylact
therapeut
strategi
complet
elimin
tumor
cell
cytotox
lymphocyt
ctl
epitop
may
good
candid
develop
effect
peptidebas
antitumor
vaccin
fact
studi
anim
model
alreadi
shown
ctl
safe
erad
tumor
cell
vivo
date
mani
therapeut
vaccin
strategi
develop
target
protein
among
synthet
peptidebas
strategi
particularli
remark
advantag
conveni
lowcost
highthroughput
prepar
rare
occurr
advers
reaction
includ
gener
toxic
immunosuppress
autoimmun
importantli
gener
specif
ctl
possibl
select
length
amino
acid
sequenc
suitabl
particular
applic
howev
peptidebas
vaccin
character
weak
immunogen
use
alon
vivo
overcom
limit
critic
identifi
adjuv
vehicl
enhanc
immunogen
peptid
specif
immunogen
larg
number
immun
adjuv
investig
purpos
includ
aluminum
hydroxid
liposom
cytokin
granulocytemacrophag
colonystimul
factor
gmcsf
interleukin
saponin
tolllik
receptor
tlr
agonist
variou
heat
shock
protein
hsp
among
hsp
shown
especi
promis
result
heavili
pursu
tool
develop
effect
safer
cacx
vaccin
long
establish
hsp
particularli
function
effect
immunoadjuv
virtu
abil
bind
tumorspecif
peptid
howev
recent
research
indic
larger
hsp
better
suit
use
recombin
vaccin
major
hsp
eukaryot
mammalian
cell
gener
molecular
mass
kda
compos
four
function
coupl
domain
includ
ntermin
domain
mediat
atp
bind
peptidebind
domain
amino
acid
residu
sever
studi
suggest
effici
bind
larg
protein
peptid
heat
shock
condit
produc
excel
adjuv
effect
mous
b
restrict
ctl
epitop
short
peptid
span
amino
acid
residu
protein
rahynivtf
previous
shown
form
noncoval
bind
complex
molar
ratio
elicit
antitumor
immun
mice
moreov
epitop
wellknown
hlaa
human
ctl
epitop
protein
show
highaffin
bind
vitro
addit
abil
induc
peptidespecif
ctl
verifi
transgen
mice
frequent
hlaa
specif
human
popul
allel
frequenc
differ
ethnic
group
specif
random
individu
popul
china
carri
hlaa
rank
first
frequenc
allel
frequenc
thu
peptid
vaccin
base
haplotyp
may
particularli
potent
impact
global
hpv
threat
studi
present
herein
investig
whether
ctl
respons
induc
epitop
enhanc
chaperon
molecul
found
murin
combin
heat
shock
condit
applic
novel
strategi
hlaa
transgen
mous
model
valid
complex
induc
function
cytotox
cell
peptidespecif
manner
effici
complet
freund
adjuv
cfa
emulsifi
peptid
alon
mice
plasmid
cell
line
hlaa
transgen
mice
femal
week
old
express
background
obtain
jackson
laboratori
bar
harbor
mice
hous
pathogenfre
environ
procedur
involv
anim
carri
approv
local
ethic
committe
third
militari
medic
univers
tumor
cell
deriv
primari
pulmonari
epitheli
cell
mice
cotransform
chara
oncogen
purchas
cell
center
cam
shanghai
china
eukaryot
express
plasmid
b
express
domain
hlaa
domain
b
plasmid
number
addgen
cambridg
transfect
cell
use
lipofectamin
invitrogen
carlsbad
ca
maintain
complet
rpmi
medium
gibco
invitrogen
supplement
fetal
bovin
serum
fb
hyclon
logan
ut
mm
lglutamin
gibco
mm
gibco
uml
penicillin
gml
streptomycin
gibco
humidifi
atmospher
co
air
establish
stabl
b
express
cell
cell
select
addit
gml
sangon
shanghai
china
complet
rpmi
medium
week
control
cell
dead
cell
antigenprocessingdefect
cell
line
obtain
american
type
cultur
collect
manassa
va
maintain
previous
describ
synthet
peptid
hpv
peptid
epitop
ymldlqpett
synthes
free
carboxi
terminu
use
solidphas
strategi
autom
multipl
peptid
synthes
shenzhen
hanyu
pharmaceut
corp
shenzhen
china
carbonyl
fmoc
chemistri
puriti
synthes
peptid
detect
reversephas
highperform
liquid
chromatographi
hplc
synthes
peptid
dissolv
dimethyl
sulfoxid
dmso
store
fluorescein
isothiocyan
fitc
label
peptid
fitc
conjug
n
terminu
pure
synthes
shenzhen
hanyu
pharmaceut
corp
dissolv
phosphatebuff
salin
pb
dmso
store
express
purif
identif
recombin
protein
cdna
clone
vector
qiagen
hilden
germani
transform
recombin
escherichia
coli
cultur
luria
broth
induct
addit
mm
iptg
mhsp
protein
tag
purifi
cultur
supernat
use
ninitrilotriacet
acid
ninta
column
wash
extens
triton
guanidinehcl
remov
endotoxin
describ
previous
lipopolysaccharid
lp
final
protein
solut
undetect
limulu
test
prepar
commerci
sourc
lp
free
cusabio
wuhan
china
store
concentr
recombin
protein
measur
bradford
assay
protein
puriti
assess
sdspage
assay
coomassi
blue
stain
western
blot
analysi
use
confirm
ident
purifi
recombin
protein
rabbit
polyclon
antibodi
stressgen
ann
arbor
mi
primari
antibodi
chemiluminesc
kit
roch
diagnost
limit
shanghai
china
use
detect
target
protein
band
follow
exposur
xray
film
reconstitut
confirm
peptid
complex
noncoval
complex
gener
accord
previous
publish
protocol
bind
peptid
briefli
fitclabel
peptid
mix
molar
ratio
pb
supplement
mm
atp
mm
mgcl
min
incub
sampl
cool
room
temperatur
h
free
peptid
clear
sampl
size
exclus
filtrat
method
use
microcon
filter
millipor
billerica
molecular
mass
cutoff
kda
remain
bound
complex
evalu
nativ
page
nupag
novex
trisacet
minigel
invitrogen
carri
darkroom
gel
observ
photograph
fluoresc
imag
stain
coomassi
brilliant
blue
pagerul
prestain
protein
ladder
fermenta
vilniu
lithuania
use
determin
protein
complex
size
immun
cell
purif
cultur
mice
divid
group
five
administ
one
follow
immunogen
via
intraperiton
ip
rout
complex
g
plu
g
complex
g
plu
g
g
alon
g
alon
g
alon
l
pb
mice
immun
twice
initi
immun
occur
day
booster
given
day
later
anoth
group
five
mice
immun
subcutan
sc
g
togeth
cfa
boost
g
togeth
incomplet
freund
adjuv
sigmaaldrich
st
loui
mo
immun
agent
dissolv
pb
achiev
final
volum
immun
group
mice
euthan
week
second
vaccin
spleen
asept
remov
made
singlecel
splenocyt
suspens
red
blood
cell
remov
treat
suspens
red
blood
cell
lysi
buffer
roch
diagnost
limit
remain
splenocyt
wash
pb
contain
fb
cultur
ml
cultur
plate
complet
tcell
medium
rpmi
contain
fb
mm
lglutamin
penicillin
uml
streptomycin
gml
co
cultur
cell
subject
variou
assay
includ
lymphocyt
prolifer
enzymelink
immunosorb
assay
elisa
enzymelink
immunosorb
spot
elispot
cytotox
splenocyt
prolifer
assay
splenocyt
variou
group
immun
mice
cultur
cellswel
l
triplic
cultur
plate
presenc
peptid
day
co
number
viabl
cell
determin
use
bromid
mtt
test
kit
sigmaaldrich
cytotox
assay
splenocyt
rpmi
contain
fb
variou
group
immun
mice
stimul
vitro
gml
murin
interleukin
uml
r
system
minneapoli
mn
day
cultur
viabl
splenocyt
use
effector
cell
meanwhil
cell
preincub
peptid
gml
h
wash
rpmi
contain
fb
use
target
cell
stimul
splenocyt
cell
alon
use
target
cell
control
furthermor
test
whether
cell
mice
immun
immunogen
recogn
epitop
natur
process
protein
cell
appli
target
cell
ctl
activ
effector
cell
measur
use
nonradioact
cytotox
kit
promega
madison
wi
previous
describ
briefli
stimul
splenocyt
cocultur
target
cell
differ
effectortarget
cell
et
ratio
vbottom
cultur
plate
co
h
incub
supernat
lwell
remov
substrat
mix
lwell
ad
plate
incub
dark
min
room
temperatur
reaction
termin
ad
l
stop
solut
acet
acid
sampl
absorb
wavelength
measur
elisa
plate
reader
biorad
hercul
ca
spontan
releas
lactat
dehydrogenas
ldh
target
effector
cell
assess
incub
target
cell
absenc
effector
cell
vice
versa
maximum
releas
ldh
determin
incub
target
cell
triton
assay
medium
specif
lysi
percentag
calcul
experiment
releas
effector
spontan
releas
target
spontan
releas
target
maximum
releas
target
spontan
releas
experi
repeat
three
time
elisa
level
gamma
interferon
cell
cultur
supernat
determin
use
mous
elisa
kit
r
system
accord
manufactur
instruct
briefli
splenocyt
supernat
lwell
harvest
day
cultur
ad
precoat
well
incub
room
temperatur
h
wash
time
biotinyl
antibodi
lwell
ad
plate
incub
h
addit
incub
enzym
conjug
reaction
stop
ad
l
stop
solut
optic
densiti
read
nm
three
independ
experi
carri
sampl
elispot
assay
antigenspecif
cell
detect
mous
elispot
kit
dakewei
shenzhen
china
accord
manufactur
protocol
briefli
precoat
plate
activ
ad
lymphospot
serumfre
medium
splenocyt
cellswel
l
ad
triplic
well
incub
presenc
either
gml
gml
co
h
posit
control
well
cellswel
establish
phytohemagglutinin
alon
gml
well
contain
lymphospot
serumfre
medium
establish
measur
background
signal
ddh
lml
ad
well
plate
incub
min
extens
wash
time
biotinyl
antibodi
ab
lwell
ad
plate
incub
h
five
wash
streptavidin
horseradish
peroxidas
hrp
lwell
ad
plate
incub
h
room
temperatur
final
five
wash
immunoreact
spot
develop
incub
aminoethyl
carbazol
aec
chromogen
solut
lwell
min
room
temperatur
spot
count
use
dissect
microscop
tumor
challeng
experi
evalu
therapeut
antitumor
effect
variou
immunogen
tumor
establish
sc
inject
cell
right
flank
hlaa
transgen
mice
day
day
mice
obviou
tumor
develop
assign
arbitrarili
group
mice
ip
inject
differ
immun
formul
l
total
volum
pb
day
tumor
volum
record
twice
week
measur
perpendicular
tumor
diamet
calip
calcul
shortest
diamet
longest
diamet
surviv
mice
record
daili
group
statist
analysi
data
express
mean
standard
error
mean
sem
comparison
experiment
group
made
use
student
test
analysi
varianc
anova
follow
bonferroni
post
hoc
test
differ
consid
statist
signific
p
valu
differ
heat
shock
condit
recombin
prepar
describ
previou
studi
recombin
protein
prepar
yield
high
puriti
shown
sdspage
assay
fig
lane
purifi
commerci
sourc
confirm
western
blot
fig
lane
prior
studi
laboratori
indic
effici
bind
epitop
peptid
rahynivtf
heat
shock
temperatur
herein
determin
whether
also
bind
peptid
fitclabel
peptid
incub
bind
buffer
heat
shock
condit
complex
subject
nondenatur
page
analysi
imag
fluoresc
imag
shown
lane
fig
fitc
signal
detect
posit
correspond
protein
gel
indic
could
complex
peptid
howev
complex
run
sdspage
gel
fluoresc
signal
observ
posit
correspond
band
data
shown
indic
noncoval
bind
peptid
complex
promot
antigenspecif
splenocyt
prolifer
hlaa
transgen
mice
immun
variou
immunogen
splenocyt
harvest
restimul
vitro
peptid
day
mtt
assay
show
mice
immun
complex
exhibit
strongest
lymphocyt
prolifer
compar
group
fig
complex
cfaemulsifi
peptid
prime
similar
lymphocyt
prolifer
level
markedli
higher
observ
group
contrast
spleen
cell
mice
immun
stimul
signific
cell
prolifer
vitro
restimul
evidenc
index
significantli
differ
detect
pb
negativecontrol
group
chaperon
complex
stimul
enhanc
secret
immun
mice
determin
whether
complex
stimul
cellular
immun
respons
product
splenocyt
immun
mice
measur
use
elisa
method
hlaa
transgen
mice
immun
twice
indic
immunogen
interv
immun
two
week
second
immun
splenocyt
harvest
immun
mice
stimul
vitro
describ
shown
fig
significantli
increas
product
observ
supernat
cultur
splenocyt
mice
vaccin
chaperon
complex
compar
supernat
cell
mice
vaccin
immunogen
howev
complex
cfaemulsifi
peptid
stimul
much
higher
product
immunogen
pb
control
compar
elisa
method
elispot
assay
sensit
function
method
measur
product
singlecel
level
therefor
elispot
employ
investig
whether
complex
elicit
antigenspecif
product
accord
elisa
result
immun
mice
prime
cell
compar
group
fig
complex
cfaemulsifi
peptid
prime
cell
alon
pb
control
fig
complex
prime
potent
specif
cytotox
next
use
ldh
releas
assay
investig
whether
complex
elicit
antigenspecif
ctl
hlaa
transgen
mice
immun
complex
sever
control
agent
cell
puls
peptid
use
target
cell
cell
express
molecul
process
intracellular
antigen
shown
fig
mice
vaccin
complex
cytolyt
activ
effector
cell
cell
puls
peptid
significantli
higher
group
et
ratio
ratio
howev
stimul
higher
cytotox
alon
alon
alon
pb
control
untreat
cell
use
target
cell
investig
whether
natur
killer
nk
cell
contribut
nonspecif
cytotox
assay
appar
differ
cytotox
observ
group
fig
investig
whether
ctl
immun
hlaa
transgen
mice
recogn
epitop
natur
process
protein
use
target
cell
cell
control
target
cell
result
similar
obtain
load
cell
use
target
cell
fig
likewis
none
cytotox
cell
group
kill
cell
fig
potent
vivo
antitumor
effect
immun
complex
therapeut
efficaci
establish
tumor
vivo
import
indic
potenti
applic
vaccin
thu
determin
whether
enhanc
ex
vivo
cell
respons
gener
complex
elicit
therapeut
antitumor
effect
perform
vivo
tumor
treatment
experi
use
tumor
model
sc
inocul
cell
hlaa
transgen
mice
shown
fig
although
cfaemulsifi
immun
inhibit
tumor
growth
tumorbear
mice
treat
complex
exhibit
stronger
decreas
tumor
growth
tumorbear
mice
treat
immunogen
p
likewis
kaplanmei
surviv
analysi
show
tumorchalleng
mice
treat
complex
exhibit
markedli
prolong
surviv
howev
cfaemulsifi
immun
also
produc
signific
antitumor
effect
compar
alon
alon
alon
pb
group
fig
util
hsp
peptid
adjuv
wide
research
hsp
famili
member
success
appli
clinic
set
vaccin
adjuv
target
cancer
infect
peptid
also
complex
either
tissuederiv
recombin
hsp
vitro
gener
hsppeptid
complex
use
peptidespecif
vaccin
howev
clinic
applic
tissuederiv
hsp
limit
requir
surgic
specimen
suffici
quantiti
purifi
hsp
previous
verifi
significantli
enhanc
immun
restrict
hpv
epitop
mous
model
remain
unknown
whether
enhanc
immunogen
differ
major
histocompat
complex
mhc
restrict
epitop
peptid
current
studi
investig
efficaci
molecular
chaperon
immunoadjuv
enhanc
immunogen
peptid
vaccin
result
prove
broad
applic
peptid
vaccin
strategi
base
chaperon
select
epitop
peptid
target
molecul
previous
verifi
hlaa
ctl
epitop
furthermor
epitop
detect
patient
squamou
cell
carcinoma
oropharynx
specif
ctl
cell
line
establish
sever
strategi
base
peptid
includ
dna
vaccin
format
singl
amino
acid
substitut
shown
improv
immunogen
vivo
system
howev
human
epitop
less
extens
studi
mous
b
restrict
ctl
epitop
thu
investig
epitop
necessari
especi
improv
immun
epitop
transgen
anim
model
direct
implic
applic
human
hpv
infect
case
ctl
respons
key
compon
immun
respons
tumor
cell
therefor
focu
studi
observ
whether
enhanc
effici
activ
expans
function
ctl
specif
peptid
inde
result
present
herein
demonstr
complex
elicit
epitopespecif
splenocyt
prolifer
specif
secret
importantli
complex
immun
produc
strong
cytolyt
effect
target
cell
puls
peptid
even
transgen
cell
process
present
epitop
protein
cell
besid
strong
ex
vivo
antitumor
immun
respons
complex
also
reduc
tumor
volum
enhanc
surviv
tumorbear
mice
complex
show
higher
antitumor
effect
cfaemulsifi
peptid
observ
accord
previou
find
wang
et
al
show
chaperon
gener
higher
antitumor
immun
respons
addit
also
found
complex
stronger
complex
prime
host
antitumor
respons
observ
may
reflect
fact
much
higher
proteinand
peptidebind
affin
famili
conclus
data
encourag
investig
promis
candid
immunomodul
peptidebas
human
cancer
vaccin
epitop
